GL1X · GenesisL1 explorer

Research workbench

Crystal structure of HLA-A*0201 complexed with a peptide with the carboxyl-terminal group substituted by a methyl group

Analyse Crystal structure of HLA-A*0201 complexed with a peptide with the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1B0R
Type
protein
Length
376 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein (HLA-A*0201); Protein (influenza matrix peptide)
UniProt
P01892, P61769
Pockets
5 · best druggability 0.69

Structure

x-ray diffraction · 3 distinct chains · 20% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein (HLA-A*0201)protein26928% helix, 38% strandP01892
BProtein (HLA-A*0201)protein1000% helix, 52% strandP61769
CProtein (influenza matrix peptide)protein70% helix, 0% strand—

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16870.690.7764empty
2880.430.7923empty
3900.370.7620empty
4700.370.7817empty
5700.350.7616empty

Interfaces

2 interfaces between chains.

  • A–B · 1405 Ų buried · 17 hydrogen bonds · protein-protein
  • A–C · 728 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide, 1 modified (disulfide, nonstandard).

Compared structures

  • 1B0R · Crystal structure of HLA-A*0201 complexed with a peptide with the carboxyl-terminal group… · the same entry in another collection · chain A against A, TM-score 1.00
  • P61769 · AlphaFold monomer V2.0 prediction for beta-2-microglobulin (P61769) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.